Emily Schwarz

Immunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Inhibition of Bruton’s tyrosine kinase with PD-1 blockade modulates T cell activation in solid tumors”.

Inhibition of Bruton’s tyrosine kinase with PD-1 blockade modulates T cell activation in solid tumors

JCI Insight(2024)10.1172/jci.insight.169927

N/A

0.312DataRank · unranked

6 citations

Brooke Benner, Robert Wesolowski, Dionisia Quiroga, Logan Good, Steven Sun +27 more

A Phase II Clinical Trial of Nivolumab and Temozolomide for Neuroendocrine Neoplasms

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-1552

N/A

0DataRank · unranked

36 citations

Brooke Benner, Lai Wei, Vineeth Sukrithan, Ashima Goyal, Ye Zhou +17 more

Analysis of Changes in Plasma Cytokine Levels in Response to IL12 Therapy in Three Clinical Trials

Cancer Research Communications(2023)10.1158/2767-9764.crc-23-0122

N/A

0DataRank · unranked

4 citations

Brooke Benner, Lianbo Yu, Fode Tounkara, William E. Carson, Emily Schwarz

Data from A Phase II Clinical Trial of Nivolumab and Temozolomide for Neuroendocrine Neoplasms

(2023)10.1158/1078-0432.c.6533090

N/A

0DataRank · unranked

0 citations

Brooke Benner, Lai Wei, Vineeth Sukrithan, Ashima Goyal, Ye Zhou +17 more

Data from A Phase II Clinical Trial of Nivolumab and Temozolomide for Neuroendocrine Neoplasms

(2023)10.1158/1078-0432.c.6533090.v1

N/A

0DataRank · unranked

0 citations

Brooke Benner, Lai Wei, Vineeth Sukrithan, Ashima Goyal, Ye Zhou +17 more

Inhibition of miRNA associated with a disease-specific signature and secreted via extracellular vesicles of systemic lupus erythematosus patients suppresses target organ inflammation in a humanized mouse model

Frontiers in Immunology(2024)10.3389/fimmu.2023.1090177

N/A

0DataRank · unranked

10 citations

Emily Schwarz, B. Zeno, Shane Bruckner, Rosana A. Mesa, Kyle Jablonski +4 more

Trabectedin promotes oncolytic virus antitumor efficacy, viral gene expression, and immune effector function in models of bone sarcoma

Molecular Therapy Oncology(2024)10.1016/j.omton.2024.200886

N/A

0DataRank · unranked

8 citations

Mark A. Currier, Andrea M. Glaspell, Chun‐Yu Chen, Matthew V. Cannon, Maren Cam +13 more

Trabectedin Enhances Oncolytic Virotherapy by Reducing Barriers to Virus Spread and Cytotoxic Immunity in Preclinical Pediatric Bone Sarcoma

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.03.02.582994

N/A

0DataRank · unranked

1 citations

Mark A. Currier, Andrea M. Glaspell, Chun‐Yu Chen, Matthew V. Cannon, Maren Cam +13 more

Loss of miR-1469 expression mediates melanoma cell migration and invasion

PLoS ONE(2021)10.1371/journal.pone.0256629

N/A

0DataRank · unranked

6 citations

Zoe Barricklow, Emily Schwarz, Maribelle Moufawad, John H. Howard, Lianbo Yu +4 more

BRD4 inhibition leads to MDSC apoptosis and enhances checkpoint blockade therapy

Journal of Clinical Investigation(2025)10.1172/jci181975

N/A

0DataRank · unranked

6 citations

Andrew Stiff, Alvin Liu, Robert Wesolowski, Emily Schwarz, Ian C. Garbarine +23 more